A chlamydial type III-secreted effector protein (Tarp) is predominantly recognized by antibodies from humans infected with Chlamydia trachomatis and induces protective immunity against upper genital tract pathologies in mice

This publication has 78 references indexed in Scilit:

• Chlamydia trachomatis tarp is phosphorylated by src family tyrosine kinases
  Biochemical and Biophysical Research Communications, 2008
• Characterization of Fifty Putative Inclusion Membrane Proteins Encoded in theChlamydia trachomatisGenome
  Infection and Immunity, 2008
• Caspase-1 Contributes toChlamydia trachomatis-Induced Upper Urogenital Tract Inflammatory Pathologies without Affecting the Course of Infection
  Infection and Immunity, 2008
• Intranasal Vaccination with a Secreted Chlamydial Protein Enhances Resolution of GenitalChlamydia muridarumInfection, Protects against Oviduct Pathology, and Is Highly Dependent upon Endogenous Gamma Interferon Production
  Infection and Immunity, 2007
• Chlamydial Protease-Like Activity Factor Induces Protective Immunity against Genital Chlamydial Infection in Transgenic Mice That Express the Human HLA-DR4 Allele
  Infection and Immunity, 2006
• Chlamydial TARP is a bacterial nucleator of actin
  Proceedings of the National Academy of Sciences, 2006
• Inhibition of Matrix Metalloproteinases Protects Mice from Ascending Infection and Chronic Disease Manifestations Resulting from UrogenitalChlamydia muridarumInfection
  Infection and Immunity, 2006
• A small-molecule inhibitor of type III secretion inhibits different stages of the infectious cycle of Chlamydia trachomatis
  Proceedings of the National Academy of Sciences, 2006
• The protective efficacy of chlamydial protease-like activity factor vaccination is dependent upon CD4+ T cells
  Cellular Immunology, 2006
• Treatment of Chlamydia trachomatis with a small molecule inhibitor of the Yersinia type III secretion system disrupts progression of the chlamydial developmental cycle
  Molecular Microbiology, 2006